Liraglutide, a Once-Daily Human GLP-1 Analog, Is Equally Effective and Tolerated Independent of Administration Time (Morning vs Evening)

被引：0
|
作者：
Kaku, Kohei
Rasmussen, Mads
Katayama, Yasuyuki
Seino, Yutaka
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A144 / A144
页数：1
相关论文
共 50 条
  • [21] The Relationship between Pharmacokinetics of the Once-Daily Human GLP-1 Analog Liraglutide and Pharmacodynamic Effects on Glycemia, Gastric Emptying and Energy Intake
    Flint, Anne
    Hindsberger, Charlotte
    DIABETES, 2010, 59 : A420 - A420
  • [22] Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes
    Seino, Y.
    Rasmussen, M. F.
    Nishida, T.
    Kaku, K.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1013 - 1022
  • [23] Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes
    Horowitz, M.
    Flint, A.
    Doran, S.
    Rasmussen, M. F.
    Kapitza, C.
    Andreasen, A. H.
    Jones, K. L.
    Zdravkovic, M.
    Chapman, I. M.
    DIABETOLOGIA, 2008, 51 : S355 - S355
  • [24] Absence of QTc Prolongation in a Thorough QT Study With Subcutaneous Liraglutide, a Once-Daily Human GLP-1 Analog for Treatment of Type 2 Diabetes
    Chatterjee, Dhruba J.
    Khutoryansky, Naum
    Zdravkovic, Milan
    Sprenger, Craig R.
    Litwin, Jeffrey S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (11): : 1353 - 1362
  • [25] BAMBUTEROL IN THE TREATMENT OF ASTHMA - A PLACEBO-CONTROLLED COMPARISON OF ONCE-DAILY MORNING VS EVENING ADMINISTRATION
    DALONZO, GE
    SMOLENSKY, MH
    FELDMAN, S
    GNOSSPELIUS, Y
    KARLSSON, K
    CHEST, 1995, 107 (02) : 406 - 412
  • [26] The Pharmacokinetics, Pharmacodynamics, and Tolerability of Liraglutide, a Once-Daily Human GLP-1 Analogue, After Multiple Subcutaneous Administration in Healthy Chinese Male Subjects
    Jiang, Ji
    Zhang, Jianyan
    Jacobsen, Lisbeth V.
    Hu, Pei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (12): : 1620 - 1627
  • [27] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
    Flint, A.
    Kapitza, C.
    Hindsberger, C.
    Zdravkovic, M.
    DIABETOLOGIA, 2008, 51 : S354 - S354
  • [28] The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels
    Flint, Anne
    Kapitza, Christoph
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A165 - A165
  • [29] The once-daily human GLP-1 analog liraglutide reduces body weight in subjects with type 2 diabetes, irrespective of body mass index at baseline
    Russell-Jones, David
    Shaw, Jonathan E.
    Brandle, Michael
    Matthews, David
    Frid, Anders
    Zdravkovic, Milan
    Schmitz, Ole
    DIABETES, 2008, 57 : A593 - A594
  • [30] Treatment with Liraglutide, a Once-Daily Human GLP-1 Analog, for 52 Weeks Reduces Weight and Waist Circumference: A Randomized Placebo-Controlled Trial
    Astrup, Arne
    Al Hakim, Mazin
    Savolainen, Markku J.
    Van Gaal, Luc
    Finer, Nick
    Harper, Angela
    Lean, Michael E. J.
    Niskanen, Leo
    Frederik, Mads
    Rissanen, Aila
    Rossner, Stephan
    OBESITY, 2009, 17 : S51 - S51
12345